UNSPSC 85881704: Nonimaging nuclear medicine assay of blood using iodine 125 (i-125)

This classification denotes the group of activities that yields an intervention or procedure of nonimaging nuclear medicine assay of blood using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code C763HZZ

UNSPSC 85881704 Nonimaging nuclear medicine assay of blood using iodine 125 (I-125), a Commodity code, shows no relevant recent state and local procurement activity. The three most recent opportunities posted under this code—a diagnostic imaging PACS system solicitation from San Mateo Medical Center, a special education contracted services RFP from Birdville Independent School District in Texas, and a temporary health professional staffing qualification vehicle from the County of Santa Clara Health System—are plainly unrelated to iodine-125 radioimmunoassay testing or nuclear medicine blood assays. The mismatch suggests either miscoding of opportunities in the source data or minimal real activity in this narrow commodity category at the state and local level.

No further analysis of issuing-body mix, geographic spread, or recent opportunity detail is warranted under this code. Vendors pursuing nuclear medicine laboratory services or radioimmunoassay testing should monitor other UNSPSC categories related to laboratory testing, clinical diagnostics, or health care services rather than rely on activity under this commodity code.